We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.54%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$11.5B
AUM Growth
+$3.09B
(+37%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
1,665
New
559
Increased
260
Reduced
246
Closed
589
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 13.08% |
| 3 | Financials | 11.26% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Morgan Stanley
MS
$340B
| $33.8M | 0.29% |
700,353
+228,321
| +48% | +$9.59M |
|
77
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $33.6M | 0.29% |
+300,000
| New | +$29.5M |
|
78
Simon Property Group
SPG
$72.3B
| $32.9M | 0.29% |
+481,062
| New | +$30.2M |
|
79
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.9B
| $32.8M | 0.28% |
200,000
+100,000
| +100% | +$16.5M |
|
|
NVRO
80
DELISTED
NEVRO CORP.
NVRO
| $32.6M | 0.28% |
273,105
+148,324
| +119% | +$17.6M |
|
81
Viavi Solutions
VIAV
$9.66B
| $32.6M | 0.28% |
2,559,495
+2,260,419
| +756% | +$27.1M |
|
82
Veeva Systems
VEEV
$37.4B
| $32.3M | 0.28% |
+137,650
| New | +$27.3M |
|
83
Floor & Decor
FND
$6.68B
| $32.1M | 0.28% |
+556,107
| New | +$25.4M |
|
84
Fortive
FTV
$18.6B
| $32M | 0.28% |
749,693
+25,449
| +4% | +$993K |
|
85
Hilton Worldwide
HLT
$71.5B
| $31.7M | 0.28% |
+432,077
| New | +$32.1M |
|
|
RDS.A
86
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $31.6M | 0.27% |
965,562
+951,137
| +6,594% | +$32.6M |
|
87
CALL
Wells Fargo
WFC
$264B
| $31.1M | 0.27% |
1,215,000
+635,000
| +109% | +$17.4M |
|
88
Kraft Heinz
KHC
$30B
| $31.1M | 0.27% |
+973,997
| New | +$29.2M |
|
89
Goldman Sachs
GS
$303B
| $31M | 0.27% |
156,883
+72,013
| +85% | +$13.5M |
|
90
Moderna
MRNA
$23.6B
| $30.9M | 0.27% |
+481,631
| New | +$26.4M |
|
91
PUT
Gilead Sciences
GILD
$165B
| $30.8M | 0.27% |
+400,000
| New | +$30.7M |
|
92
SLB Ltd
SLB
$75B
| $30.7M | 0.27% |
1,667,833
+703,188
| +73% | +$12.3M |
|
93
VanEck Semiconductor ETF
SMH
$71.8B
| $30.6M | 0.27% |
400,000
| – | – |
|
94
Deere & Co
DE
$168B
| $30.5M | 0.26% |
194,198
+61,478
| +46% | +$8.91M |
|
95
Thermo Fisher Scientific
TMO
$220B
| $30.3M | 0.26% |
+83,732
| New | +$28.1M |
|
96
TE Connectivity
TEL
$62.6B
| $30.2M | 0.26% |
+370,698
| New | +$27.9M |
|
97
Carter's
CRI
$1.47B
| $30.1M | 0.26% |
+373,285
| New | +$29.7M |
|
98
O'Reilly Automotive
ORLY
$76.3B
| $30M | 0.26% |
+1,067,940
| New | +$27.9M |
|
99
Principal Financial Group
PFG
$24.3B
| $29.9M | 0.26% |
719,306
+426,936
| +146% | +$15.6M |
|
100
Cognex
CGNX
$11.3B
| $29.8M | 0.26% |
499,679
+477,584
| +2,162% | +$25.9M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Balyasny Asset Management held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Balyasny Asset Management deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Balyasny Asset Management's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Balyasny Asset Management added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Balyasny Asset Management's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Balyasny Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Balyasny Asset Management's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Balyasny Asset Management opened 559 new positions and closed 589 in Q2 2020.
- Balyasny Asset Management's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.